This finding aligns with existing literature that suggests metabolic changes in high‐grade gliomas, such as reduced reliance on oxidative phosphorylation and increased glycolytic activity, may suppress certain enzymes like KAT8 [20]. This evidence concerns the gene KAT8 and central nervous system cancer.